CD4 cell recovery during successful antiretroviral therapy in naive HIV-infected patients: The role of intravenous drug use

AIDS

Volumn 18, Issue 16, 2004, Pages 2210-2212

  Dronda, Fernando ^a   Zamora, Javier ^a   Moreno, Santiago ^a   Moreno, Ana ^a   Casado, José L ^a   Muriel, Alfonso ^a   Pérez Elías, María J ^a   Antela, Antonio ^a   Moreno, Leonor ^a   Quereda, Carmen ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DNA; VIRUS RNA;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CONVALESCENCE; DNA DAMAGE; DNA REPAIR; DRUG USE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOTHERAPY; LYMPHOCYTE COUNT; LYMPHOCYTOPOIESIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; T LYMPHOCYTE; TREATMENT OUTCOME; VIRUS INHIBITION;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MULTIVARIATE ANALYSIS; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 7744242891     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200411050-00018     Document Type: Article

References (11)

1. Mocroft A, Lederberger B, Katlama C, Kirk O, Reiss P, d'Arminio Monforte A, et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003; 362:22-29.
2. Bagasra O, Pomerantz RJ. Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine. J Infect Dis 1993; 168:1157-1164.
3. Chiapelli F, Frost P, Manfrini E, Lee P, Pham L, García C, et al. Cocaine blunts human CD4+ cell activation. Immunopharmacology 1994; 28:233-240.
4. Roth MD, Tashkin DP, Choi R, Jamieson BD, Zack JA, Baldwin CC. Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes. J Infect Dis 2002; 185:701-705.
5. Dronda F, Moreno S, Moreno A, Casado JL, Pérez-Elías MJ, Antela A. Long-term outcomes among antiretroviral-naive human immunodeficiency virus-infected patients with small increases in CD4+ cell counts after successful virologic suppression. Clin Infect Dis 2002; 35:1005-1009.
6. Piketty C, Weiss L, Thomas F, Mohamed AS, Belec L, Kazatchkine MD. Long-term clinical outcome of human immunodeficiency virus-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimens. J Infect Dis 2001; 183:1328-1335.
7. Greub C, Lederberger B, Battegay M, Grob P, Perrin L, Furrer H, et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 2000; 356:1800-1805.
8. Peterson PK, Gekker C, Chao CC, Schut R, Molitor TW, Balfour HH. Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cells cocultures. Involvement of transforming growth factor-β. J Immunol 1991; 146:81-84.
9. Nair MPN, Chadha KC, Hewitt RC, Mahajan S, Sweet A, Schwartz SA. Cocaine differentially modulates chemokine production by mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients. Clin Diagn Lab Immunol 2000; 7:96-100.
10. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, Jacobson LP, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999; 179:859-870.
11. Pitrak DL, Bolaños, J, Hershow R, Novak RM. Discordant CD4 T lymphocyte responses to antiretroviral therapy for HIV infection are associated with ex vivo rates of apoptosis. AIDS 2001; 15:1317-1318.